Passaretti Bruno
Humanitas Gavazzeni e Castelli, Bergamo, Italy.
Int J Cardiol Cardiovasc Risk Prev. 2024 Apr 27;21:200274. doi: 10.1016/j.ijcrp.2024.200274. eCollection 2024 Jun.
Sweet Heart and Light Heart represent the first two educational formats of ITACARE-P, a recently established scientific association that joins various professionals with the aim of promoting all activities related to Cardiac Prevention and Rehabilitation. These educational formats represent opportunities for updating, comparing and sharing ideas among experts in order to standardize behaviors on hot topics. Pathologies in the metabolic field were chosen: diabetes mellitus and obesity, especially due to the cardiologist's possibility of prescribing drugs belonging to the SGLT2-i and GLP-RA classes, which have been shown to have a cardioprotective and nephroprotective effect, thus carrying a favorable influence on cardiovascular mortality. Sweet Heart and Light Heart were structured in a series of lectures alternated with "peer-to-peer" discussions; the possibilities offered by Italian National Health Service refundability in the prescription of these drugs and the difficulties that can be encountered in communicating this therapy to patients, particularly in the case of obesity where the purchase of the drug is at the patient's own expense, were examined. The results of this initiative was the drafting and publication of a position paper involving the entire Scientific Committee of the Association concerning the management of the patient suffering from diabetes mellitus in Cardiac Rehabilitation, with the peculiarities that concern the approach to the patient in this setting, such as the prescription of physical exercise in the same way as a drug, the introduction of process and outcome indicators, and the search for an anti-atherogenic or rather hemodynamic effect.
“甜心计划”和“轻松计划”代表了ITACARE-P的前两种教育形式,ITACARE-P是一个最近成立的科学协会,汇聚了各类专业人士,旨在推动与心脏预防和康复相关的所有活动。这些教育形式为专家们提供了更新知识、交流想法和分享观点的机会,以便在热门话题上规范行为。代谢领域的疾病被选为主题:糖尿病和肥胖症,特别是因为心脏病专家有可能开具属于SGLT2-i和GLP-RA类别的药物,这些药物已被证明具有心脏保护和肾脏保护作用,从而对心血管死亡率产生有利影响。“甜心计划”和“轻松计划”由一系列讲座和“同行交流”讨论交替组成;研究了意大利国家医疗服务体系对这些药物处方的报销可能性,以及在向患者传达这种治疗方法时可能遇到的困难,特别是在肥胖症患者自费购买药物的情况下。该倡议的结果是起草并发表了一份立场文件,该文件涉及协会整个科学委员会关于心脏康复中糖尿病患者管理的内容,其中包括在这种情况下对待患者的特点,例如将体育锻炼作为药物一样开具处方、引入过程和结果指标,以及寻求抗动脉粥样硬化或确切地说是血液动力学效应。